{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:32:02Z","timestamp":1782779522411,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21DA058117"],"award-info":[{"award-number":["R21DA058117"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21DA058117"],"award-info":[{"award-number":["R21DA058117"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21DA058117"],"award-info":[{"award-number":["R21DA058117"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21DA058117"],"award-info":[{"award-number":["R21DA058117"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21DA058117"],"award-info":[{"award-number":["R21DA058117"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21DA058117"],"award-info":[{"award-number":["R21DA058117"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21DA058117"],"award-info":[{"award-number":["R21DA058117"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21DA058117"],"award-info":[{"award-number":["R21DA058117"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21DA058117"],"award-info":[{"award-number":["R21DA058117"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R21DA058117"],"award-info":[{"award-number":["R21DA058117"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Addict Sci Clin Pract"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Methadone is the gold standard treatment for opioid use disorder (OUD). In the U.S., methadone is usually only available through licensed opioid treatment programs (OTPs), but a 2021 federal rule provided an opportunity for OTPs to provide methadone on mobile medication units (MMUs). MMUs operate under the license of an OTP and are subject to complex regulatory requirements. New York State provided grant funding to support OTPs to adopt MMUs, aligned with the broader goal to improve methadone access statewide. This study explored barriers and facilitators to MMU implementation across New York State from the perspectives of treatment staff and administrators.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted semi-structured interviews between June 2024 and June 2025 with 16 staff from four OTPs that adopted MMUs and one residential treatment program served by an MMU. Interviews were audio-recorded, transcribed, and analyzed using a hybrid deductive-inductive thematic analysis approach to identify implementation barriers and facilitators.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Staff described a variety of potential models for using MMUs to expand access. In New York City, MMUs were used to serve a residential substance use program. In upstate NY, MMUs were deployed to reduce travel distance in counties with few OTP options. Key facilitators of MMU implementation included leadership persistence in the face of community pushback, creativity and workarounds in the face of logistical hurdles, and support from the state agency. Key barriers included community resistance to MMUs, unclear or inconsistent guidance from the Drug Enforcement Administration, and a variety of operational challenges, such as vehicle maintenance and workforce shortages. Staff generally were positive about the opportunity to use MMUs to address access challenges.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>MMUs provide a novel approach to expand methadone access, particularly to populations not currently served by brick-and-mortar OTPs. Early implementers can provide important lessons about how to manage start-up challenges, which can guide later adopters.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13722-026-00694-y","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T11:15:38Z","timestamp":1782299738000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["\u201cHow are we going to be able to pull that off?\u201d: staff perspectives on the early implementation of mobile medication units in New York State"],"prefix":"10.1186","volume":"21","author":[{"given":"Megan","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minna","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Bessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristianny","family":"Ruelas-Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha J.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason B.","family":"Gibbons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashly E.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noa","family":"Krawczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Saloner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"694_CR1","unstructured":"Centers for Disease Control and Prevention. Provisional drug overdose death counts [Internet]. Hyattsville (MD): National Center for Health Statistics; 2024 [cited 2024 Apr 29]. Available from: https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm. Accessed 29 Apr 2024."},{"key":"694_CR2","unstructured":"New York State Office of Addiction Services and Supports. NYS overdose death dashboard [Internet]. [cited 2026 Apr 9]. Available from: https:\/\/oasas.ny.gov\/overdose-death-dashboard. Accessed 9 Apr 2026."},{"key":"694_CR3","doi-asserted-by":"publisher","DOI":"10.17226\/25310","volume-title":"Medications for Opioid Use Disorder Save Lives [Internet]","year":"2019","unstructured":"Leshner AI, Mancher M, editors. Medications for Opioid Use Disorder Save Lives [Internet]. Washington, D.C.: National Academies; 2019. [cited 2023 Oct 2]. https:\/\/doi.org\/10.17226\/25310."},{"key":"694_CR4","doi-asserted-by":"publisher","unstructured":"Suen LW, Incze M, Simon C, Englander H, Bratberg J, Groves Scott G, et al. Methadone\u2019s resurgence in bridging the treatment gap in the overdose crisis: position statement of AMERSA, Inc (Association for Multidisciplinary Education, Research, Substance Use, and Addiction). Subst Use Addict J [Internet]. 2024;45:337-345 [cited 2025 Dec 5]. Available from: https:\/\/doi.org\/10.1177\/29767342241255480.","DOI":"10.1177\/29767342241255480"},{"key":"694_CR5","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1111\/add.14991","volume":"115","author":"N Krawczyk","year":"2020","unstructured":"Krawczyk N, Mojtabai R, Stuart EA, Fingerhood M, Agus D, Lyons BC, et al. Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services. Addict Abingdon Engl. 2020;115:1683\u201394. https:\/\/doi.org\/10.1111\/add.14991.","journal-title":"Addict Abingdon Engl"},{"key":"694_CR6","unstructured":"Institute of Medicine (US) Committee on Federal Regulation of Methadone Treatment; Rettig RA, Yarmolinsky A, editors. Introduction. In: Federal regulation of methadone treatment [Internet]. Washington (DC): National Academies Press (US); 1995 [cited 2025 Dec 5]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK232114\/. Accessed 5 Dec 2025."},{"key":"694_CR7","doi-asserted-by":"publisher","first-page":"S322","DOI":"10.1093\/infdis\/jiz659","volume":"222","author":"AE Jordan","year":"2020","unstructured":"Jordan AE, Cleland CM, Wyka K, Schackman BR, Perlman DC, Nash D. Hepatitis C Virus Incidence in a Cohort in Medication-Assisted Treatment for Opioid Use Disorder in New York City. J Infect Dis [Internet]. 2020;222:S322\u201334. https:\/\/doi.org\/10.1093\/infdis\/jiz659. [cited 2025 Dec 5];.","journal-title":"J Infect Dis [Internet]"},{"key":"694_CR8","doi-asserted-by":"crossref","unstructured":"Platt L, Minozzi S, Reed J, Vickerman P, Hagan H, French C, et al. Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs - Platt, L - 2017 | Cochrane Library. [cited 2024 Sept 11]; https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD012021.pub2\/full. Accessed 11 Sept 2024.","DOI":"10.1002\/14651858.CD012021.pub2"},{"key":"694_CR9","unstructured":"Duff JH, Carter JA. Location of medication-assisted treatment for opioid addiction: in brief [Internet]. Washington (DC): Congressional Research Service; 2019 Jun. Report No.: R45782. Available from: https:\/\/sgp.fas.org\/crs\/misc\/R45782.pdf."},{"key":"694_CR10","unstructured":"National Academies of Sciences E, Epidemic AC on C the USO, Division H and M, Services B on HC, Policy B on HS, Stroud C, et al. The history of methadone and barriers to access for different populations. methad treat opioid use disord improv access regul leg change proc workshop. National Academies Press (US); 2022. pp. 13\u201328."},{"key":"694_CR11","unstructured":"Krawczyk N, Frank D. Still waiting for methadone [Internet]. 2025. Available from: URL"},{"key":"694_CR12","unstructured":"Duvall A. Administrative barriers cripple implementation of mobile opioid treatment in rural New York [Internet]. New York (NY): New York State Association for Rural Health; 2025 Sep."},{"key":"694_CR13","unstructured":"Registration requirements for narcotic treatment programs with mobile components [Internet]. Federal Register. 2021 [cited 2024 Aug 13]. Available from: https:\/\/www.federalregister.gov\/documents\/2021\/06\/28\/2021-13519\/registration-requirements-for-narcotic-treatment-programs-with-mobile-components. Accessed 13 Aug 2024."},{"key":"694_CR14","doi-asserted-by":"publisher","first-page":"108483","DOI":"10.1016\/j.jsat.2021.108483","volume":"129","author":"B Chan","year":"2021","unstructured":"Chan B, Hoffman KA, Bougatsos C, Grusing S, Chou R, McCarty D. Mobile methadone medication units: A brief history, scoping review and research opportunity. J Subst Abuse Treat. 2021;129:108483. https:\/\/doi.org\/10.1016\/j.jsat.2021.108483.","journal-title":"J Subst Abuse Treat"},{"key":"694_CR15","unstructured":"Nguyen R, Staatz C, Vine M. Implementation of mobile medication units: findings from a qualitative study [Internet]. Washington (DC): Mathematica; 2025 Jan."},{"key":"694_CR16","unstructured":"New York State Office of Addiction Services and Supports. Mobile medication unit [Internet]. [cited 2024 Jun 17]. Available from: https:\/\/oasas.ny.gov\/rfa\/mobile-med-unit. Accessed 17 June 2024."},{"key":"694_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13012-022-01245-0","volume":"17","author":"LJ Damschroder","year":"2022","unstructured":"Damschroder LJ, Reardon CM, Widerquist MAO, Lowery J. The updated Consolidated Framework for Implementation Research based on user feedback. Implement Sci [Internet]. 2022;17:75. https:\/\/doi.org\/10.1186\/s13012-022-01245-0. [cited 2024 Sept 23];.","journal-title":"Implement Sci [Internet]"},{"key":"694_CR18","unstructured":"Dedoose [Internet]. Los Angeles (CA): SocioCultural Research Consultants, LLC; 2021 [cited 2024 Jun 14]. Available from: https:\/\/www.dedoose.com\/. Accessed 14 June 2024."},{"key":"694_CR19","doi-asserted-by":"publisher","unstructured":"McDonald N, Schoenebeck S, Forte A. Reliability and inter-rater reliability in qualitative research: norms and guidelines for CSCW and HCI practice. Proc ACM Hum Comput Interact [Internet]. 2019 [cited 2024 Jun 14];3:72:1-72:23. Available from: https:\/\/doi.org\/10.1145\/3359174.","DOI":"10.1145\/3359174"},{"key":"694_CR20","unstructured":"United Nations Statistics Division. Glossary of the 1993 SNA: definition of term [Internet]. [cited 2026 Apr 10]. Available from: https:\/\/unstats.un.org\/unsd\/nationalaccount\/glossary.asp. Accessed 10 Apr 2026."},{"key":"694_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsat.2019.05.002","volume":"103","author":"N Krawczyk","year":"2019","unstructured":"Krawczyk N, Buresh M, Gordon MS, Blue TR, Fingerhood MI, Agus D. Expanding low-threshold buprenorphine to justice-involved individuals through mobile treatment: Addressing a critical care gap. J Subst Abuse Treat. 2019;103:1\u20138. https:\/\/doi.org\/10.1016\/j.jsat.2019.05.002.","journal-title":"J Subst Abuse Treat"},{"key":"694_CR22","doi-asserted-by":"publisher","unstructured":"Chatterjee A, Baker T, Rudorf M, Walt G, Stotz C, Martin A, et al. Mobile treatment for opioid use disorder: implementation of community-based, same-day medication access interventions. J Subst Use Addict Treat [Internet]. 2024 [cited 2025 Nov 12];159. Available from: https:\/\/doi.org\/10.1016\/j.josat.2023.209272.","DOI":"10.1016\/j.josat.2023.209272"},{"key":"694_CR23","doi-asserted-by":"publisher","first-page":"209428","DOI":"10.1016\/j.josat.2024.209428","volume":"164","author":"MT Davis","year":"2024","unstructured":"Davis MT, Tschampl C, Hodgkin D, Regis C, Taveras E, Plant B, et al. Mobile clinics for opioid use disorders: What they do and how they do it. A qualitative analysis. J Subst Use Addict Treat [Internet]. 2024;164:209428. https:\/\/doi.org\/10.1016\/j.josat.2024.209428. [cited 2024 Aug 13];.","journal-title":"J Subst Use Addict Treat [Internet]"},{"key":"694_CR24","doi-asserted-by":"publisher","unstructured":"Hallett E, Simeon E, Amba V, Howington D, McConnell KJ, Zhu JM. Factors influencing turnover and attrition in the public behavioral health system workforce: qualitative study. Psychiatr Serv [Internet]. 2024;75:55-63 [cited 2025 Oct 30]. Available from: https:\/\/doi.org\/10.1176\/appi.ps.20220516.","DOI":"10.1176\/appi.ps.20220516"},{"key":"694_CR25","unstructured":"National Center for Health Workforce Analysis. State of the behavioral health workforce [Internet]. 2025 Dec [cited 2026 Apr 9]. Available from:"},{"key":"694_CR26","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1176\/appi.ps.202000565","volume":"73","author":"J McNeely","year":"2022","unstructured":"McNeely J, Schatz D, Olfson M, Appleton N, Williams AR. How Physician Workforce Shortages Are Hampering the Response to the Opioid Crisis. Psychiatr Serv Wash D C. 2022;73:547\u201354. https:\/\/doi.org\/10.1176\/appi.ps.202000565.","journal-title":"Psychiatr Serv Wash D C"},{"key":"694_CR27","doi-asserted-by":"publisher","unstructured":"Coffee Z, Linde-Krieger L, Carter GA, Brady BR, Davis A, Crosby RA, et al. Trauma-related stress and resilience in a multistate sample of methadone treatment staff. Subst Use Rehabil [Internet]. 2025 [cited 2026 Apr 8];19:29768357251383239. Available from: https:\/\/doi.org\/10.1177\/29768357251383239.","DOI":"10.1177\/29768357251383239"},{"key":"694_CR28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13722-023-00427-5","volume":"18","author":"RE Stewart","year":"2023","unstructured":"Stewart RE, Christian HP, Cardamone NC, Abrams C, Drob C, Mandell DS, et al. Mobile service delivery in response to the opioid epidemic in Philadelphia. Addict Sci Clin Pract [Internet]. 2023;18:71. https:\/\/doi.org\/10.1186\/s13722-023-00427-5. [cited 2026 Apr 10];.","journal-title":"Addict Sci Clin Pract [Internet]"},{"key":"694_CR29","doi-asserted-by":"publisher","first-page":"222","DOI":"10.15288\/jsad.21-00438","volume":"84","author":"D Frank","year":"2023","unstructured":"Frank D, Krawczyk N, Arshonsky J, Bragg MA, Friedman SR, Bunting AM. COVID-19-Related Changes to Drug-Selling Networks and Their Effects on People Who Use Illicit Opioids. J Stud Alcohol Drugs. 2023;84:222\u20139. https:\/\/doi.org\/10.15288\/jsad.21-00438.","journal-title":"J Stud Alcohol Drugs"},{"key":"694_CR30","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.drugalcdep.2009.05.014","volume":"104","author":"KE McCollister","year":"2009","unstructured":"McCollister KE, French MT, Pyne JM, Booth B, Rapp R, Carr C. The cost of treating addiction from the client\u2019s perspective. Drug Alcohol Depend [Internet]. 2009;104:241\u20138. https:\/\/doi.org\/10.1016\/j.drugalcdep.2009.05.014. [cited 2024 Sept 30];.","journal-title":"Drug Alcohol Depend [Internet]"},{"key":"694_CR31","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13722-022-00316-3","volume":"17","author":"E Pasman","year":"2022","unstructured":"Pasman E, Kollin R, Broman M, Lee G, Agius E, Lister JJ, et al. Cumulative barriers to retention in methadone treatment among adults from rural and small urban communities. Addict Sci Clin Pract [Internet]. 2022;17:35. https:\/\/doi.org\/10.1186\/s13722-022-00316-3. [cited 2025 Nov 12];.","journal-title":"Addict Sci Clin Pract [Internet]"},{"key":"694_CR32","doi-asserted-by":"publisher","unstructured":"Joudrey PJ, Chadi N, Roy P, Morford KL, Bach P, Kimmel S, et al. Pharmacy-based methadone dispensing and drive time to methadone treatment in five states within the United States: a cross-sectional study. Drug Alcohol Depend [Internet]. 2020 [cited 2025 Jul 22];211:107968. Available from: https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.107968.","DOI":"10.1016\/j.drugalcdep.2020.107968"},{"key":"694_CR33","unstructured":"New York State Office of Addiction Services and Supports. Ambulatory patient groups (APG) clinical and Medicaid billing guidance [Internet]. 2025 [cited 2025 Dec 5]. Available from: https:\/\/oasas.ny.gov\/system\/files\/documents\/2025\/11\/apg-manual.pdf. Accessed 5 Dec 2025."},{"key":"694_CR34","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13012-018-0789-7","volume":"13","author":"AM Bach-Mortensen","year":"2018","unstructured":"Bach-Mortensen AM, Lange BCL, Montgomery P. Barriers and facilitators to implementing evidence-based interventions among third sector organisations: a systematic review. Implement Sci [Internet] BioMed Cent. 2018;13:103. https:\/\/doi.org\/10.1186\/s13012-018-0789-7. [cited 2025 Nov 14];.","journal-title":"Implement Sci [Internet] BioMed Cent"},{"key":"694_CR35","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13643-018-0734-5","volume":"7","author":"S-A Li","year":"2018","unstructured":"Li S-A, Jeffs L, Barwick M, Stevens B. Organizational contextual features that influence the implementation of evidence-based practices across healthcare settings: a systematic integrative review. Syst Rev [Internet] BioMed Cent. 2018;7:72. https:\/\/doi.org\/10.1186\/s13643-018-0734-5. [cited 2025 Nov 14];.","journal-title":"Syst Rev [Internet] BioMed Cent"}],"container-title":["Addiction Science &amp; Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13722-026-00694-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-026-00694-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-026-00694-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T09:58:56Z","timestamp":1782467936000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13722-026-00694-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["694"],"URL":"https:\/\/doi.org\/10.1186\/s13722-026-00694-y","relation":{},"ISSN":["1940-0640"],"issn-type":[{"value":"1940-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"11 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was conducted in accordance with the norms of the Belmont Report. Ethical approval for this study was obtained from Johns Hopkins Institutional Review Board (IRB00421590). Verbal informed consent was obtained prior to data collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}